Clinical Trial Update: Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment Thrombolysis in Myocardial Infarction - Study 25 (ExTRACT-TIMI25) [Phase 3]

View source ↗

Summary

ExTRACT-TIMI25 is a Phase 3 trial evaluating enoxaparin with thrombolysis for acute myocardial infarction in STEMI. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Myocardial Infarction
• St-segment Elevation Myocardial Infarction

Drugs mentioned

• Enoxaparin (enoxaparin sodium)

Snippet

Sponsor: Sanofi | Conditions: Myocardial Infarction, Acute ST-Segment Elevation | Phase 3 | Status: COMPLETED